| 【Company Research】I-Mab BioPharma (IMAB US) – Strong cash balance to fund business operations |
| 【Company Research】AK Medical (1789 HK) – Net profit beat due to significant volume growth post VBP |
| 【Company Research】Joinn Laboratories (6127 HK) – Accelerating growth momentum |
| 【Company Research】Haidilao (6862 HK) – Reformed successfully and may reopen stores |
| 【Company Research】SANY International (631 HK) – Beat expectation: 2Q22 core profit +43% YoY on strong margin recovery |
| 【Economic Perspectives】China Economy – Growth remained weak and may slowly rise ahead |
| 【Company Research】Baidu (BIDU US) – The worst is behind; eyes on 2H22E recovery |
| 【Company Research】Kintor Pharmaceutical (9939 HK) – Encouraging data of pyrilutamide for treatment of AGA |
| 【Company Research】JS Global Lifestyle (1691 HK) – Guidance revised but outlook is getting better |
| 【Company Research】BYDE (285 HK) – 1H22 weakness in-line; positive signs of earnings recovery in 2H22 |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
